725683-06-7

Basic information

• Product Name: [2-(4-BROMO-PHENYL)-ETHYL]-METHYL-AMINE
• Synonyms: N-[2-(4-Bromophenyl)ethyl]-N-methylamine;[2-(4-BROMO-PHENYL)-ETHYL]-METHYL-AMINE;2-(4-Bromophenyl)-N-methylethanamine;4-BroMo-N-Methyl-benzeneethanaMine
• CAS NO: 725683-06-7
• Molecular Formula: C₉H₁₂BrN
• Molecular Weight: 214.1
• Mol File: 725683-06-7.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: Room temperature.
• CAS DataBase Reference: [2-(4-BROMO-PHENYL)-ETHYL]-METHYL-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: [2-(4-BROMO-PHENYL)-ETHYL]-METHYL-AMINE(725683-06-7)
• EPA Substance Registry System: [2-(4-BROMO-PHENYL)-ETHYL]-METHYL-AMINE(725683-06-7)

Safety Data

• Hazardous Substances Data: 725683-06-7(Hazardous Substances Data)

Usage

Description

[2-(4-Bromo-phenyl)-ethyl]-methyl-amine is a chemical compound with the molecular formula C10H13BrN. It is an amine derivative that features a bromine-substituted phenyl ring and a methyl-ethyl group. This versatile chemical is known for its potential to exhibit a range of biological activities due to its unique structural features, making it a valuable component in medicinal chemistry and a promising candidate for the development of new drugs and therapeutic agents.

Uses

Used in Organic Synthesis:
[2-(4-Bromo-phenyl)-ethyl]-methyl-amine is utilized as a reagent in organic synthesis for its ability to participate in various chemical reactions, contributing to the formation of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, [2-(4-Bromo-phenyl)-ethyl]-methyl-amine is employed as a key intermediate in the development of new drugs and therapeutic agents. Its structural features allow it to be a building block for creating novel compounds with potential medicinal properties.
Used in Medicinal Chemistry:
[2-(4-Bromo-phenyl)-ethyl]-methyl-amine is used as a versatile chemical in medicinal chemistry to explore its potential biological activities. Its bromine-substituted phenyl ring and methyl-ethyl group may contribute to its interaction with biological targets, making it a candidate for further research and development in the field of drug discovery.

Upstream product

• 7713-76-0 2-(4-bromophenyl)-N-methylethanamide 
• 85356-68-9 1-bromo-4-(2-iodoethyl)benzene 
• 74-89-5 methylamine 

Downstream Products

• 1361990-87-5 3,7-bis((2-(4-bromophenyl)ethyl)(methyl)amino)phenothiazin-5-ium iodide 
• 943740-82-7 1-(4-bromophenethyl)-3-(3-cyano-4-(ethylsulfonyl)phenyl)-1-methylurea 
• 943740-92-9 benzyl 4-bromophenethyl(methyl)carbamate 

Relevant articles and documents

Iron-Catalyzed Intramolecular C—H Amidation of N-Benzoyloxyureas

A redox-neutral Fe-catalyzed intramolecular C—H amidation of N-benzoyloxyureas is described. This methodology employs a simple iron complex in situ generated from Fe(OTf)2 and bipyridine as the catalyst and N-benzoyloxyureas as the nitrene prec

Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer

G-quadruplexes are non-canonical DNA secondary structures putatively present in the promoter regions of oncogenes in the human genome. The targeting of promoter G-quadruplex structures to repress oncogene transcription represents a potential anticancer st

MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS

The present invention relates generally to novel macrocycles of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, thereof, wherein the variables A, B, L, M, W, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein. These compounds are selective inhibitors of the serine protease coagulation factor VIIa which can be used as medicaments.